LONDON, Dec. 16, 2016 /PRNewswire/ -- The LAMEA coronary stent market was estimated to attain a market size of $1.3 billion in 2015 and is expected to grow at a CAGR of 7.9 % during the forecast period (2016 - 2022). The Brazil region would continue its dominance and would attain a market size of $1.3 billion by 2022. The Drug Eluting Stents segment is expected to further grow at a CAGR of 7.1% during the forecast period thereby maintaining its dominance in the LAMEA market. However, the Bioresorable Vascular Scaffold segment would grow at the highest CAGR.
With innovative ideas and presence of large market players, the coronary stents market has tremendous potential during the days ahead. Advancements in the field of interventional cardiology and minimally invasive techniques have significantly influenced the market potential for therapeutic applications of stents. Coronary stents such as bare metal stents, drug-eluting stents, and bioabsorbable stents can be used to treat coronary artery diseases (CAD).
The report aims at providing stakeholders with an in-depth analysis of the North America Coronary stents market. The current & future market trends of the technology are pinpointed in a highly strategic manner. With the report in hand, investors can gain highly strategic market insights to base their discretion for investments. Market estimation of the current market and estimations through 2016-2022 would provide the complete financial potency of the market.
Key market participants profiled in the report includes:
Abbott, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, Stentys SA, MicroPort Scientific Corporation and C. R. Bard, Inc.
Download the full report: https://www.reportbuyer.com/product/4407732/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lamea-coronary-stents-market-2016-2022-300379768.html